Insights On Upstream Manufacturing
-
The Critical Role Of Amino Acids In Biopharmaceutical Manufacturing
10/14/2026
Lot-to-lot control, documentation, and supply continuity for media amino acids become increasingly pressing questions as mammalian and microbial processes move toward commercial manufacturing.
-
High-Yield Cell Therapy Bioproduction
10/14/2026
Producing billions of dental pulp stem cells strains static culture and complicates harvest. A closed planar perfusion approach offers another route, with scale-up lessons from one developer.
-
Intensifying Cell Production Processes Through Real-Time Control
10/14/2026
Real-time lactate readings steering ATF perfusion automatically offer a route to denser, more scalable NK cell cultures while maintaining viability, a contrast with the limits of batch and fed-batch.
-
High-Yield MSC Expansion At The Forefront Of Cell Therapy Advancement
10/14/2026
As MSC therapies move from autologous to allogeneic use and higher cell doses, the question shifts from efficacy to reliable expansion. See how design, closed handling, and media shape scale-up.
-
Optimization Of AAV Production Using New Statistical Design Of Experiment
10/13/2026
Space filling experimental designs cover the full design space, not just its edges, and may offer a more accurate way to model response surfaces and set AAV operating ranges.
-
Effective And Efficient High mAb Titer Production Methods
10/13/2026
Titer and timeline differences in minipool generation for mammalian cell line development, followed by fed batch performance of single cell clones across five mAbs.
-
Adherent PSC Expansion: Key Considerations For Scalable Manufacturing
10/13/2026
Adherent multilayer vessels let PSC cultures scale without changing familiar media and handling, but coating volumes, seeding density, and harvest recovery all need rethinking.
-
Efficient Tech Transfer For Ultra-Scale Biomanufacturing
10/13/2026
Biologics manufacturing is entering a fourth wave, driven by ultra-large bioreactors and outsourced production, where successful technology transfer is critical to scale, efficiency, and supply.
-
Characterization Of Oxygen Mass Transfer Rate (Kla)
10/13/2026
A response surface model reveals how agitation, airflow, and volume affect oxygen transfer (kLa) across bioreactor scales, improving scale-up predictability.
-
Strategies To Accelerate Gene Therapy Process Development
10/13/2026
Gene therapy developers are accelerating timelines with platform approaches, DoE, stronger development-manufacturing alignment, and PAT tools to reach late-phase manufacturing faster.